Opportunity Information: Apply for CDC RFA IP11 1102
Apply for CDC RFA IP11 1102
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Integrated Economic, Dynamic Disease, Risk and Decision Analytic Modeling of Global and Domestic Policy Issues for Polio" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Mar 25, 2011 and posted on Mar 25, 2011.
- Applicants must submit their applications by Apr 25, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,150,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Kid Risk, Inc is the only qualified agency to provide the services specified under this acquisition because A. Kid Risk, Inc has developed the only available integrated dynamic global model of polio risks and costs, a process that involved 6 years of extensive literature review, data gathering and model development and iteration, with extensive collaboration with CDC, WHO, and other international polio experts. CDC has been a major partner in polio eradication since 1991. The program is aware of, and works closely with, all the partners who are involved in this enormous public health project.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, issued by the Centers for Disease Control and Prevention (CDC), focuses on supporting the US Government-endorsed Global Polio Eradication Initiative (GPEI) by funding advanced analytic work that combines economics, infectious disease transmission dynamics, risk analysis, and decision modeling. In practical terms, the goal is to strengthen how policymakers and public health leaders evaluate polio-related strategies by using an integrated modeling framework that can simulate disease spread and program outcomes while also accounting for costs, uncertainties, and trade-offs. The opportunity aligns with Healthy People 2020 priorities, specifically in the areas of Global Health and Immunization and Infectious Diseases, reflecting its intent to inform both international eradication planning and US domestic policy decisions connected to polio prevention and risk management.
The funding mechanism is a cooperative agreement, which generally indicates substantial involvement by the CDC during the project rather than a hands-off grant. The work falls under the health activity category, and the relevant CFDA listing is 93.185 (Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects). The announcement anticipated a single award, with an estimated total funding amount of $1,150,000. There was no cost-sharing or matching requirement, meaning the recipient would not be expected to contribute additional funds as a condition of receiving the award. Notably, both the award ceiling and floor were listed as zero, which often appears in postings where a specific total amount is stated but the agency does not publish a standard per-award range in that field.
A key feature of this opportunity is its highly restricted eligibility. The CDC stated that Kid Risk, Inc. was the only qualified applicant able to provide the required services because it had developed what the announcement describes as the only available integrated, dynamic global model of polio risks and costs. According to the eligibility justification, this capability was the product of six years of extensive literature review, data collection, model development, and iterative refinement, carried out with significant collaboration involving CDC, the World Health Organization (WHO), and other international polio experts. In effect, the agency framed this as a sole-source type of scientific and technical capacity that could not be readily replicated or substituted by another organization within the timeframe and requirements of the program.
From a policy and program perspective, the modeling emphasis suggests the funded work was intended to help decision-makers compare eradication and control options, anticipate the consequences of different vaccination strategies, and estimate economic implications under varying risk scenarios. Because polio eradication involves complex endgame challenges, such as managing vaccine-derived poliovirus risks, planning outbreak responses, and making decisions about vaccination after eradication milestones, an integrated model can provide a structured way to test assumptions and explore "what-if" scenarios before implementing high-stakes public health actions. The grant description also underscores CDC's long-standing role in polio eradication efforts since 1991 and highlights the agency's close coordination with global partners involved in what it characterizes as a major public health undertaking.
Administratively, the opportunity was posted on March 25, 2011, with an application closing date of April 25, 2011, and it was later archived on May 25, 2011. For applicants or organizations needing assistance accessing the full announcement at the time, the CDC Procurement and Grants Office (PGO) was listed as the point of contact, with a phone number (770-488-2700) and email (PGOTIM@cdc.gov). Overall, the opportunity can be understood as targeted federal support for sophisticated, decision-relevant modeling to guide polio eradication policy, with funding structured around a single specialized provider identified as uniquely capable of delivering the integrated analytic platform needed for GPEI-related decisions.
Frequently Asked Questions (FAQs)
What is this CDC grant opportunity about?
This opportunity supports the US Government-endorsed Global Polio Eradication Initiative (GPEI) by funding advanced analytic work. The funded work is focused on combining economics, infectious disease transmission dynamics, risk analysis, and decision modeling into an integrated framework that helps decision-makers evaluate polio-related strategies.
What is the main purpose of the funded work?
The goal is to strengthen how policymakers and public health leaders assess polio eradication and control strategies by using an integrated modeling framework. The framework is intended to simulate disease spread and program outcomes while also accounting for costs, uncertainties, and trade-offs to support decision-making.
What types of analysis does the opportunity emphasize?
The opportunity emphasizes integrated analytic work that combines:
- Economics (including cost implications)
- Infectious disease transmission dynamics (how polio spreads under different conditions)
- Risk analysis (uncertainty and risk scenarios)
- Decision modeling (comparing strategies and trade-offs)
How is this opportunity connected to the Global Polio Eradication Initiative (GPEI)?
The work is intended to support GPEI-related decision-making by providing modeling that can compare eradication and control options, anticipate consequences of different vaccination strategies, and estimate economic implications under varying risk scenarios.
How does this align with Healthy People 2020 priorities?
The announcement states that it aligns with Healthy People 2020 priorities in Global Health and Immunization and Infectious Diseases. This reflects an intent to inform international eradication planning and US domestic policy decisions related to polio prevention and risk management.
What is the funding mechanism for this award?
The funding mechanism is a cooperative agreement. This generally indicates substantial involvement by the CDC during the project rather than a hands-off grant structure.
What does "cooperative agreement" imply for how the project is run?
Based on how the mechanism is described, a cooperative agreement implies the CDC is expected to have substantial involvement during the project. In other words, it is not described as a purely recipient-led effort with minimal agency interaction.
What is the activity category for this opportunity?
The work falls under the health activity category.
What CFDA program listing applies to this opportunity?
The relevant CFDA listing is 93.185: Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects.
How many awards were anticipated?
The announcement anticipated a single award.
What was the estimated total funding amount?
The estimated total funding amount stated in the announcement was $1,150,000.
Was cost sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement, meaning the recipient would not be required to contribute additional funds as a condition of receiving the award.
Why were the award ceiling and floor listed as zero?
The posting listed both the award ceiling and floor as zero, while also stating an estimated total funding amount. The announcement notes that this can occur in postings where a specific total amount is provided but the agency does not publish a standard per-award range in those particular fields.
Who was eligible to apply?
Eligibility was described as highly restricted. The CDC stated that Kid Risk, Inc. was the only qualified applicant able to provide the required services.
Why was eligibility limited to Kid Risk, Inc.?
The CDC justified the restriction by stating that Kid Risk, Inc. had developed what the announcement described as the only available integrated, dynamic global model of polio risks and costs. The capability was described as the product of six years of literature review, data collection, model development, and iterative refinement, with significant collaboration involving CDC, the World Health Organization (WHO), and other international polio experts.
Is this essentially a sole-source type of opportunity?
The announcement frames it as a unique scientific and technical capability that could not be readily replicated or substituted by another organization within the timeframe and requirements of the program, which is consistent with a sole-source type of justification in practice.
What kinds of policy decisions is the modeling intended to support?
The modeling emphasis suggests it was intended to help decision-makers compare eradication and control options, anticipate the consequences of different vaccination strategies, and estimate economic implications under varying risk scenarios.
What "endgame" polio challenges does the opportunity highlight?
The description points to complex endgame challenges such as:
- Managing vaccine-derived poliovirus risks
- Planning outbreak responses
- Deciding about vaccination after eradication milestones
The integrated model is presented as a way to test assumptions and explore "what-if" scenarios before implementing high-stakes public health actions.
What does the CDC say about its role in polio eradication?
The description underscores CDC's long-standing role in polio eradication efforts since 1991 and highlights close coordination with global partners as part of a major public health undertaking.
When was the opportunity posted and when did it close?
The opportunity was posted on March 25, 2011, and the application closing date was April 25, 2011.
When was the opportunity archived?
It was later archived on May 25, 2011.
Who was the point of contact for assistance with the announcement?
The CDC Procurement and Grants Office (PGO) was listed as the point of contact for assistance accessing the full announcement.
What contact information was provided for the CDC PGO?
Phone: 770-488-2700
Email: PGOTIM@cdc.gov
In simple terms, what was being funded?
Targeted federal support for sophisticated, decision-relevant modeling intended to guide polio eradication policy, structured around a single specialized provider identified by CDC as uniquely capable of delivering the needed integrated analytic platform for GPEI-related decisions.
Browse more opportunities from the same category: Health
Next opportunity: National Park Service Archeological Field School
Previous opportunity: Postdoctoral Research Training in Obstetric Fetal Pharmacology (T32)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP11 1102
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP11 1102) also looked into and applied for these:
| Funding Opportunity |
|---|
| Translation of Pluripotent Stem Cell Therapies for Blood Diseases (R01) Apply for PA 11 186 Funding Number: PA 11 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 1112 Funding Number: CDC RFA PS11 1112 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $135,000 |
| Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1) Apply for RFA AI 11 002 Funding Number: RFA AI 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $19,000,000 |
| Initiatives to Educate State Officials and Policy Makers about Priority Public Health Issues Related to the Prevention and Control of Sexually Transmitted Diseases (STDs) and Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome ( Apply for CDC RFA PS11 1118 Funding Number: CDC RFA PS11 1118 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Eliminating Mother to Child HIV Transmission in the United States through Continuous Quality Improvement The FIMR HIV Prevention Methodology Apply for CDC RFA PS11 1116 Funding Number: CDC RFA PS11 1116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| PPHF 2012 Immunization Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA IP11 1107PPHF11 Funding Number: CDC RFA IP11 1107PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Next Generation PrEP II (R01) Apply for RFA AI 11 023 Funding Number: RFA AI 11 023 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Cooperative Agreements for Screening, Brief Intervention and Referral to Treatment Apply for TI 11 005 Funding Number: TI 11 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,666,000 |
| Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54) Apply for PAR 11 187 Funding Number: PAR 11 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33) Apply for RFA MH 12 050 Funding Number: RFA MH 12 050 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Strengthening Angolan Systems for Health (SASH) Apply for RFA674 11 32 Funding Number: RFA674 11 32 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $33,000,000 |
| Support of NIAMS Program Project Grants (P01) Apply for PAR 11 188 Funding Number: PAR 11 188 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Dental Reimbursement Program Apply for HRSA 11 097 Funding Number: HRSA 11 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability Apply for CDC RFA CK11 0010101PPHF11 Funding Number: CDC RFA CK11 0010101PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,508,825 |
| Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9020302PPHF11 Funding Number: CDC RFA DP09 9020302PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrating Multi Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1) Apply for RFA MH 12 020 Funding Number: RFA MH 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 11 189 Funding Number: PAR 11 189 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Public Prevention Health Fund State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9010201PPHF11 Funding Number: CDC RFA DP09 9010201PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 071 Funding Number: HRSA 11 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State Implementation Planning Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 081 Funding Number: HRSA 11 081 Agency: Health Resources and Services Administration Category: Health Funding Amount: $75,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP11 1102", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.